Society seeks to democratize people’s access to products and information about cannabis derivatives
At 11:11 he became a partner at Anna Medicina Endocannabinoid, a company specializing in the medical cannabis and biotechnology segment.
The company’s businesses include the first cannabinoid medicine center in Brazil, which seeks to democratize people’s access to products and information about cannabis derivatives; the Anna Express marketplace (anna.express), which sells specialized products and its own line of CBD products, Eva.
Present since the conception of the business model, the agency will also be responsible for all of the company’s marketing and communications, in addition to assuming the role of partner and CMO (Chief Marketing Officer), taking care of branding, strategy, creation of B2B and B2C campaigns. , social, digital, medical communication and at points of sale, encompassing the complete patient journey.
“Brazil is a market with enormous potential for medicinal cannabis, considering the number of patients treated annually in public and private health systems. Being Anna’s partners leaves us able to participate in all decision-making, not just in the area of communication and marketing, applying creativity to influence the business as a whole”, analyzed Wilson Mateos, partner and coCCO of 11:11.
The communication strategy will take place on several fronts, the main ones being with patients (individuals or associations), healthcare professionals and medical institutions, which implies projects for targeted media, social media, events and courses, always respecting sectoral regulations.
In addition to 11:11, Anna’s executive management is made up of the company Productora Uruguaya de Cannabis Medicinal (PUCMED); professionals Marcelo Velo and CEO Priscilla Patitucci.
Operating in a market that is still under regulation, Anna’s business is projected to earn R$5 million in revenue in 2024, with growth to R$35 million in 2026.
“Anna is a complete platform on the subject, comprising the product, information for patients and doctors, the consultation and purchase process, the marketplace, reception centers and delivery logistics. Our strategic role is to make this journey more popular, more contemporary, less serious, at the same time that we deal with the taboos inherent to the topic through cutting-edge information, brought to people in a palatable way”, added Mateos.
